Immatics N.V. (NASDAQ: IMTX)
$12.49
-0.0600 ( -0.48% ) 20.3K
Immatics NV is a biotechnology company that is engaged in the research and development of T-cell redirecting immunotherapies for the treatment of cancer patients. The company earns revenue through strategic collaboration agreements with third-party pharmaceutical and biotechnology companies.
Market Data
Open
$12.49
Previous close
$12.55
Volume
20.3K
Market cap
$1.28B
Day range
$12.37 - $13.37
52 week range
$7.15 - $13.77
SEC Fillings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| 6-k | Quarterly Reports | 148 | Aug 17, 2023 |
| 6-k | Quarterly Reports | 3 | Aug 10, 2023 |
| 6-k | Quarterly Reports | 3 | Jul 24, 2023 |